Saudi Food and Drug Authority signs MoU with UK regulator to boost medical innovation
The Saudi Food and Drug Authority has signed an MoU with the UK's MHRA to support medical innovation and improve access to treatments while ensuring safety and quality.
Key Takeaways
AIThe Saudi Food and Drug Authority has signed a memorandum of understanding with the UK Medicines and Healthcare products Regulatory Agency (MHRA) to enhance the evaluation of innovative therapies and facilitate timely patient access, while maintaining standards of safety, quality, and efficacy.
The agreement was signed on the sidelines of the DIA-MHRA Global Summit, held in London on November 16 and 17, 2026.
The MoU was signed by Dr. Hisham bin Saad Aljadhey, CEO of the Saudi Food and Drug Authority, and Lawrence Tallon, CEO of the UK agency, in the presence of Professor Anthony Harnden, Chair of the MHRA. Both sides also discussed cooperation priorities in light of recent scientific and regulatory developments.
Areas of collaboration include the assessment of treatments for rare diseases, advanced therapies, and biotechnology products, as well as sharing expertise in the use of artificial intelligence, modeling, and computer simulation in clinical studies and trials. This aims to clarify regulatory requirements for developers at early stages, particularly when developing treatments for patients with limited therapeutic options.
The memorandum also covers the exchange of information and expertise on the registration and evaluation of medical products, good manufacturing practices and quality systems, product inspection and analysis, and supply chain monitoring. These efforts are intended to support the safety of medical products in both countries' markets and strengthen the ability to identify associated risks.
This cooperation supports the goals of Saudi Vision 2030 to improve quality of life by facilitating patient access to safe and effective treatments, and aligns with the National Biotechnology Strategy by developing local capabilities and fostering innovation in the sector.
